Taisho Pharmaceutical Holdings Co Ltd:企業の戦略・SWOT・財務分析

【英語タイトル】Taisho Pharmaceutical Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report

MarketLineが出版した調査資料(MLINE7096585)・商品コード:MLINE7096585
・発行会社(調査会社):MarketLine
・発行日:2017年1月31日
・ページ数:35
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・産業分野:医療・製薬
◆販売価格オプション(消費税別)
Single UserUSD175 ⇒換算¥19,075見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD350 ⇒換算¥38,150見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD525 ⇒換算¥57,225見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000を加算
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

SummaryTaisho Pharmaceutical Holdings Co Ltd – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Findings
- Detailed information on Taisho Pharmaceutical Holdings Co Ltd required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Taisho Pharmaceutical Holdings Co Ltd in the form of a SWOT analysis
- An in-depth view of the business model of Taisho Pharmaceutical Holdings Co Ltd including a breakdown and examination of key business segments
- Intelligence on Taisho Pharmaceutical Holdings Co Ltd’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Taisho Pharmaceutical Holdings Co Ltd, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons To Buy
- Gain understanding of Taisho Pharmaceutical Holdings Co Ltd and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Taisho Pharmaceutical Holdings Co Ltd as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Taisho Pharmaceutical Holdings Co Ltd’s business structure, strategy and prospects.

Key Highlights
Taisho Pharmaceutical Holdings Co Ltd (Taisho Pharmaceutical) is a pharmaceutical company. The company is involved in the development, manufacture and marketing of various pharmaceutical products. The company’s products include self-medication drugs and prescription pharmaceutical. Its self-medication products are marketed under the brand names, including pabron, lipovitan D, riup, livita, naron, colac, zena and among others. Self-Medication also offers real estate leasing, facility management and hotel management services. The company also offer products under the brand names such as include zosyn, clarith, edirol, palux, ozex, geninax, lorcam, pentcillin, tomiron and among others. The company sells macrolide antibiotic clarith through Abbott Laboratories in the US. It distributes products through its subsidiaries located in the Philippines, Indonesia, Malaysia, Thailand, Vietnam, China, Hong Kong, Taiwan, and the US. Taisho Pharmaceutical is headquartered in Tokyo, Japan.

【レポートの目次】

Company Snapshot
Taisho Pharmaceutical Holdings Co Ltd: Company Overview
Taisho Pharmaceutical Holdings Co Ltd: Overview and Key Facts
Taisho Pharmaceutical Holdings Co Ltd: Overview
Taisho Pharmaceutical Holdings Co Ltd: Key Facts
Taisho Pharmaceutical Holdings Co Ltd: Key Employees
Taisho Pharmaceutical Holdings Co Ltd: Major Products and Services
Taisho Pharmaceutical Holdings Co Ltd: Company History
Taisho Pharmaceutical Holdings Co Ltd: Management Statement
Taisho Pharmaceutical Holdings Co Ltd: Locations and Subsidiaries
Taisho Pharmaceutical Holdings Co Ltd: Key Competitors
Taisho Pharmaceutical Holdings Co Ltd: Company Analysis
Taisho Pharmaceutical Holdings Co Ltd: Business Description
Taisho Pharmaceutical Holdings Co Ltd: SWOT Analysis
Taisho Pharmaceutical Holdings Co Ltd: SWOT Overview
Taisho Pharmaceutical Holdings Co Ltd: Strengths
Taisho Pharmaceutical Holdings Co Ltd: Weaknesses
Taisho Pharmaceutical Holdings Co Ltd: Opportunities
Taisho Pharmaceutical Holdings Co Ltd: Threats
Taisho Pharmaceutical Holdings Co Ltd: Corporate Financial Deals Activity
Taisho Pharmaceutical Holdings Co Ltd: Financial Deals Overview
Taisho Pharmaceutical Holdings Co Ltd: Targets and Partners
Taisho Pharmaceutical Holdings Co Ltd: Top Deals 2013 – 2017YTD*
Taisho Pharmaceutical Holdings Co Ltd: Mergers and Acquisitions
Taisho Pharmaceutical Holdings Co Ltd: Partnership
Taisho Pharmaceutical Holdings Co Ltd: Recent Developments
Taisho Pharmaceutical Holdings Co Ltd: News and Events Summary
Taisho Pharmaceutical Holdings Co Ltd: Regulatory and Legal Events
Appendix
Contact Us
Methodology
Definitions
About Datamonitor

Table 1: Taisho Pharmaceutical Holdings Co Ltd: Key Facts
Table 2: Taisho Pharmaceutical Holdings Co Ltd: Key Employees
Table 4: Taisho Pharmaceutical Holdings Co Ltd: Key Competitors
Table 5: Taisho Pharmaceutical Holdings Co Ltd: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Taisho Pharmaceutical Holdings Co Ltd: Deal Activity by Deal Type - Volume (2013 - YTD*2017)
Table 7: Taisho Pharmaceutical Holdings Co Ltd: MandA Average Deal Size - Value (US$m)
Table 8: Taisho Pharmaceutical Holdings Co Ltd: Targets and Partners
Table 9: Taisho Pharmaceutical Holdings Co Ltd: Top Deals 2013 - 2017YTD*
Table 10: Taisho Pharmaceutical Holdings Co Ltd: MandA Volume and Value Trend (2013 - YTD*2017)
Table 11: Taisho Pharmaceutical Holdings Co Ltd: MandA Activity by Geography (2013 - YTD*2017)
Table 12: Taisho Pharmaceutical Holdings Co Ltd: Partnership Volume and Value Trend (2013 - YTD*2017)
Table 13: Taisho Pharmaceutical Holdings Co Ltd: Partnership Trend by Deal Type (2013 - YTD*2017)
Table 14: Taisho Pharmaceutical Holdings Co Ltd: News and Events Summary
Table 15: Taisho Pharmaceutical Holdings Co Ltd: Regulatory and Legal Events

Figure 1: Taisho Pharmaceutical Holdings Co Ltd: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Taisho Pharmaceutical Holdings Co Ltd: Deal Activity by Deal Type - Volume (2013 - YTD*2017)
Figure 3: Taisho Pharmaceutical Holdings Co Ltd: MandA Average Deal Size - Value (US$m)
Figure 4: Taisho Pharmaceutical Holdings Co Ltd: MandA Volume and Value Trend (2013 - YTD*2017)
Figure 5: Taisho Pharmaceutical Holdings Co Ltd: MandA Activity by Geography (2013 - YTD*2017)
Figure 6: Taisho Pharmaceutical Holdings Co Ltd: Partnership Volume and Value Trend (2013 - YTD*2017)
Figure 7: Taisho Pharmaceutical Holdings Co Ltd: Partnership Trend by Deal Type (2013 - YTD*2017)

★調査レポート[Taisho Pharmaceutical Holdings Co Ltd:企業の戦略・SWOT・財務分析] (コード:MLINE7096585)販売に関する免責事項を必ずご確認ください。
★調査レポート[Taisho Pharmaceutical Holdings Co Ltd:企業の戦略・SWOT・財務分析]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆